Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities:
Net loss	$ (3,236,763)	$ (1,915,327)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and depreciation	608	1,588
Non-cash lease expense	31,867	29,265
Share-based compensation	63,599	59,961
Issuance of common stock to vendors for services	30,000
Change in fair value of convertible debt		(165,382)
Change in operating assets and liabilities:
Contracts and grants receivable		54,225
Prepaid expenses and other current assets	605,534	414,138
Research and development incentives receivable		17,379
Operating lease liability	(32,737)	(29,359)
Accounts payable and accrued expenses	976,785	391,929
Accrued compensation	(285,905)	(200,899)
Net cash flows from operating activities	(1,847,012)	(1,342,482)
Financing activities:
Proceeds from issuance of common stock pursuant to At Market Issuance Sales Agreement	2,697,542
Issuance costs associated with public offerings		(8,992)
Convertible debt repayments	(1,372,873)
Net cash flows from financing activities	1,324,669	(8,992)
Effect of exchange rate on cash and cash equivalents		(3,136)
Net decrease in cash and cash equivalents	(522,343)	(1,354,610)
Cash and cash equivalents at beginning of year	7,819,514	8,446,158
Cash and cash equivalents at end of year	7,297,171	7,091,548
Supplemental information:
Cash paid for state income taxes	56,169	17,965
Cash paid for interest	35,044	64,047
Cash paid for lease liabilities:
Operating lease	34,875	34,100
Non-cash investing and financing activities:
Pontifax conversion of portion of debt principal into common stock		99,416
Deferred issuance cost reclassified to additional paid-in capital	$ 60,011
Offering costs included in accounts payable		$ 123,689